Realising the next generation of PCR diagnostics

ML 3+1About Enigma

Enigma Diagnostics is taking PCR-based testing out of the laboratory with a range of simple-to-use products.

Enigma Technology

Proprietary technology providing the next generation of integrated and automated real-time PCR-based diagnostics.

Enigma Instruments

The Enigma ML provides fully integrated and automated raw sample to result, real-time PCR diagnostic testing for laboratories, local hospitals, at point-of-care locations.

Press Releases:
Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman Biochemistry and Announces US$50 Million Investment
22nd October 2014
Enigma Diagnostics and China’s ICDC Announce Collaboration to Develop MDx Infectious Disease Assays on Enigma ML system for use at Point-of-Care
15th May 2014
Enigma Diagnostics Secures Additional Technology Strategy Board Funding for Multi-Drug Resistant Tuberculosis Assay
11th March 2014
View all Press Releases
See us at:

Dusseldorf, ABHI Stand, G191 Hall 16

20-23 November 2013

Los Angeles Convention Center, stand 3136

15th -19th July 2012

Arab Health, Stand RD37

23 – 26 Jan 2012